Critical parameters: For solid-phase manufacturing of therapeutic peptides

Chimica Oggi

Volumn 28, Issue 1 SUPPL., 2010, Pages 22-25

  Vorherr, Thomas ^a  

^a Bachem Holding AG   (Switzerland)

Author keywords

CGMP; Peptide manufacturing; Solid phase peptide synthesis; Therapeutic peptides

Indexed keywords

EID: 77953017385     PISSN: 0392839X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. M. Yagasaki, S. Hashimoto, Appl. Microbiol. Biotechnol., 81(1), pp. 13-22 (2008).
2. T. Bruckdorfer, O. Marder et al., Curr. Opin. Biotechnol., 5, pp. 29-43 (2004).
3. B. Merrifield, J. Am. Chem. Soc, 85, pp. 2149-2154(1963).
4. A. El-Faham, R.S. Funosas et al., J. Org. Chem., 15, pp. 9404-9416 (2009).
5. T. Vorherr, Chimica Oggi I Chemistry Today, 25( 1 ), pp. 22-24 (2007).
6. M. Mergler. F. Dick et al.. J. Peptide Sci 9. pp. 36-46 (2003).
7. L.A. Corpino, E. Krause et al.. Tetrahedron Lett., 45, pp. 7519-7523 (2004).
8. M. Mutter, A. Chandravakar et al., Angew. Chem. Inf. Ed., 43, pp. 4172-4178(2004).
9. T. Wöhr, M. Mutter, Tetrahedron Lett.. 36, pp. 3847-3848 (1995).
10. P.E. Dawson, T.W. Muir et al.. Science, 266, pp. 776-779 (1994).
11. J.W. Bode, R.M. Fox et al., Angew. Chem. Int. Ed., 45, pp. 1248-1252 (2006).
12. V. Declerk, P. Nunal et al. Angew. Chem. Int. Ed.. 48, pp. 1-5 (2009).